All the anaesthetic machines in one District General Hospital were tested for faults on three occasions for both audit and re-audit using an extended checklist based on that devised by the Association of Anaesthetists of Great Britain and Ireland. Ninety completed checklists were analysed for the audit and 24 tests revealed 236 individual faults (range 1.1–64%). Sixty-five (27.5%) could have occurred on a day-to-day basis and 171 (72.5%) of the faults were non-recurring. Following introduction of COVERS (a pre-use checklist) re-audit of 102 completed checklists showed 20 tests revealing faults on 59 occasions (range 1.0–11.6%), 16 (27%) day to day and 43 (73%) non-recurring. COVERS supported by scheduled regular comprehensive checking delegated to another time and performer is recommended as the mandatory pre-use checklist.

The present study contrasted the pharmaco-economics and analgesic efficacy of intramuscular (i.m.) opioid treatment with a parenteral disposable patient-controlled analgesia (PCA) system in two groups of 20 female patients (ASA I–II, aged 35–69 years) scheduled for abdominal hysterectomy. The PCA group received a continuous infusion of 1.5 mg h−1 piritramide, a μ-opioid receptor agonist, with incremental doses of 1.5 mg (lock-out interval=15 min). The i.m. group received 0.3 mg kg−1 piritramide i.m. when requested by the patient with a minimum interval of 5 h. Pain intensity, sedation and the functional recovery of the patients were followed for 72 h post-operatively. The sum of pain intensity differences (SPID) was used as a measure of analgesic efficiency. Equipment and drug costs, and the demand on nursing time were recorded over 3 days post-operatively. The costs of PCA and i.m. therapies per patient were used to calculate the cost-benefit (cost of treatment vs. nursing time) and cost-effectiveness (cost of treatment vs. SPID) analyses. Both treatments initially provided comparable analgesia, but PCA was more efficient after 16 h and significantly reduced nursing time for pain treatment (PCA=61±4 min, i.m.=88±5 min; P<0.001). Functional recovery was not different for either treatment. Cost analysis indicated a better cost-benefit ratio for the i.m. treatment (0.35 vs. 1.1 for PCA treatment), but a similar cost-effectiveness for both treatments (PCA=1.9 Belgian Francs (BEF) unit−1 SPID; i.m.=1.7 BEF unit−1 SPID).

Summary

Background and objective: The aim of this study was to investigate the quality of intra- and postoperative analgesia obtained by alfentanil compared to that produced by peripheral blockade in children.

Methods: During sevoflurane-nitrous oxide atracurium anaesthesia for minor abdominal or genito-urinary surgery, three groups of children aged 0–8 yr received 25 μg kg−1 alfentanil intravenously (n = 28), or peripheral nerve blockade using 1 mL−1 ropivacaine 0.475% (n = 24), or 12.5 μg kg−1 alfentanil intravenously with peripheral nerve blockade using 1 mL kg−1 ropivacaine 0.475% (n = 30). Changes in blood pressure and heart rate were measured during the procedures. Postoperative pain was assessed using the face, legs, activity, cry, consolability (FLACC) observational tool for quantifying pain behaviour and a numerical scale scored by nurses, doctors, parents and children.

Results: There was no significant difference in intra- or postoperative analgesic efficacy among the three groups. Patients who received alfentanil had significantly lower heart rates than those who received nerve blockade only (96.0 ± 15.6 vs. 115.9 ± 23.2 beats min−1, P < 0.001). FLACC and numerical scale scores did not differ among the groups. There were no significant differences in incidence of vomiting or use of pain medications.

Conclusions: It was concluded that a low-dose, intravenous bolus of alfentanil may be an efficient alternative to peripheral nerve blockade in controlling pain during and after minor abdominal and genito-urinary surgery.

The occurrence of a pneumothorax in a 4-week-old infant is described. The cause of the problem is believed to have been a kink in the silastic reservoir tube. The failure of the monitors to detect the event and methods of improving safety are discussed. Difficulties may occur even with familiar equipment; the value of full monitoring and constant vigilance are stressed.

In a randomized, prospective clinical study pain relief and pulmonary function were compared after upper abdominal surgery when thoracic epidural analgesia was instituted either before or after surgery. Twenty-six patients admitted for surgery to treat gastro-oesophageal reflux received thoracic epidural analgesia as an adjunct to general anaesthesia either before or after surgery. Twelve patients received epidural mepivacaine 20 mg mL−1 and morphine perioperatively. Another 14 patients received an epidural bolus of bupivacaine 2.5 mg mL−1 and morphine after skin closure. Bupivacaine 2.5 mg mL−1 with morphine was adminstered to all patients for three postoperative days. No intergroup differences were found regarding pain at rest and mobilization. The requirement for additional analgesics was similar in both groups as well as peak expiratory flow. Thoracic epidural analgesia that had already been induced before surgery, and was continued into the postoperative period, does not seem to add any advantage regarding pain relief and lung function compared with thoracic epidural analgesia instituted in the immediate postoperative period.

Local anaesthetics injected into the epidural space may deform the dural sac to a variable degree, thereby contributing to variability in the extent of the block. We investigated deformation of the lumbar dural sac after injection into the lumbar epidural space. The subjects were 26 patients with low-back pain who underwent lumbar epidurography and computed tomographic (CT) epidurography, of whom seven also underwent myelography and computed tomographic myelography. The epidural space was entered via the sacral hiatus in 24 patients and through the L5/S1 interspace in two patients. Ten millilitres of local anaesthetic was then injected into the epidural space followed by 20 mL of contrast medium. Computed tomographic epidurography was undertaken approximately 30 min after the epidural injection at the mid-vertebral and mid-discal levels from the first lumbar through to the first sacral vertebrae. The dural sac usually showed an oval or hexagonal shape on the transverse views at the first and second lumbar vertebral levels, and the shape of an inverted triangle below the level of the third lumbar vertebra. A median line of translucency was also observed on the postero-anterior epidurographic view in 25 of the 26 patients. This line was thought to be a manifestation of the dural deformation to the inverted triangle. Dural sac deformation usually shows a specific pattern, although there are individual variations. Dural deformability is an important consideration in any analysis of the spread of epidural block or of the changes of epidural pressure after epidural injection of local anaesthetics.

A 74-year-old woman was scheduled for surgical treatment of a carpal tunnel syndrome. An intravenous (i.v.) regional anaesthetic was performed using 1% prilocaine standard technique. Three minutes after injection of the local anaesthetic mild to moderate central nervous system symptoms developed, along with tachycardia, sweating and peri-oral paraesthesia. The evolution was favourable, no convulsions or other more serious events occurred. Despite showing adequate pressure inflation the tourniquet failed to accomplish its purpose. The patient recovered well without any sequelae.

General anaesthesia for a patient with tuberous sclerosis was complicated by epilepsy. The choice of drugs was related to control of his fits and intercurrent therapy. Thiopentone, vecuronium, and nitrous oxide with isoflurane were satisfactory.

While Horner's syndrome is a rare and occasionally reported complication of epidural ‘top-ups’ administered for labour and Caesarean delivery, the case reported here followed a low-dose epidural infusion of bupivacaine. Low-dose epidural infusions have generally been regarded as a safer alternative to bolus doses in labour. It is also the case that close supervision is deemed unnecessary in some centres where the mother is receiving such an epidural infusion. This case is reported in order to highlight the potential dangers of a low-dose regime which in spite of the lack of early warning signs may be associated with a high block.

Background and objective Variability in blink duration was examined to see whether it was sensitive to sevoflurane sedation at 0.05 and 0.1 minimum alveolar concentration (MAC).

Methods Blinks were measured with an infrared transducer in eight subjects. Sedation was scored using a visual analogue scale (VAS).

Results At baseline, 0.05 and 0.1 MAC sevoflurane, respectively, the overall median value of blink duration and its interquartile range were 95 (80–110) ms, 198 (163–245) ms and 210 (130–980) ms. The median percentage of blinks exceeding 500 ms was 0% (0–0.7%), 33.3% (25.5–34.7%) and 25% (15.7–63.3%) respectively. Values during 0.05 and 0.1 MAC sevoflurane were significantly different from baseline (P < 0.035) but not from each other. Baseline visual analogue scales showed large intersubject variability. Compared with baseline, VAS scores were higher at 0.05 MAC (P < 0.035) but not at 0.1 MAC. After discontinuing sevoflurane, median blink duration returned to baseline with a recovery half-life of 2.6 min (R2 = 0.95).

Conclusion Blink duration is a sensitive measure of sevoflurane sedation even at 0.05 MAC.

Aprotinin has been reported to influence positively or negatively the process of ischaemia-reperfusion. However, it is a complex drug acting on platelets, neutrophils and coagulation, which may also have a direct effect by inhibiting intracellular proteases and free radical generation. The goal of this study was to determine the direct effects of aprotinin on the myocardial performances of an isolated blood perfused rabbit heart preparation after normothermic global ischaemia. Two groups of 10 hearts were studied. The control group (ischaemia) underwent 30 min of global normothermic ischaemia. In the aprotinin group, (aprotinin) 200 KUI mL−1 of aprotinin was added to the perfusate before ischaemia. Measurements were obtained at base-line, 10, 30 and 60 min after reperfusion. Normothermic ischaemia significantly decreased myocardial performance in both groups. After 60 min reperfusion, myocardial contractility significantly recovered in the aprotinin group compared with the ischaemia group. Aprotinin contributes significantly by limiting the consequences of ischaemia on myocardial performances. This effect may be due to a direct action of the drug because leucocytes and plasma proteins were removed in this preparation.

Summary

Background and objective: A retrospective analysis of applicants to Specialist Registrar training posts in anaesthesia in the Wessex Region of the UK was undertaken.

Methods: Applicants whose primary medical qualification was obtained in the European Economic Area were compared to applicants whose primary medical qualification was obtained outside it. The time since qualification, the time spent in anaesthesia, the time spent in other specialities, the post currently held and the success of the application were recorded.

Results: For doctors with a primary medical qualification from outside the European Economic Area, the median time since obtaining that qualification was 12.0 yr compared with 6.0 yr for doctors qualifying within it (P = 0.0001, U-test). Thirteen out of 89 (15%) doctors whose primary medical qualification was from outside the European Economic Area and 39 out of 61 (64%) doctors whose primary medical qualification was from within it were shortlisted for interview (P = 0.0001, χ2-test). Six out of 13 (46%) shortlisted doctors from outside the European Economic Area were appointed at interview compared with 24 out of 39 (62%) shortlisted doctors who qualified within it (P = 0.33, χ2-test).

Conclusions: In the Wessex Region of the UK, applicants whose primary medical qualification is obtained within the European Economic Area are approximately four times as likely to be shortlisted than doctors qualifying outside it. However, after shortlisting, both categories are equally likely to be successful at interview.

Background and aim Infusion of ketamine and midazolam can maintain prolonged anaesthesia, but delayed recovery is a limitation. We aimed to develop an approximation regimen for the infusion of ketamine and midazolam to obtain steady-state anaesthesia with acceptable recovery.

Methods Thirty-one patients undergoing radical cystect-omy were studied. The initial regimen was calculated from drug pharmacokinetic variables and tailored in a pilot study (15 patients) to develop the approximation regimen dosage. Anaesthesia was induced with midazolam (150μgkg−1) and ketamine (2mgkg−1). Tracheal intubation and ventilation with oxygen enriched air (FiO2 = 0.35) were facilitated by muscle relaxants. Anaesthesia was maintained by the approximation regimen doses. Routine monitoring was used for all patients, but pulmonary artery catheters were inserted in 11 patients, to obtain haemo-dynamic and oxygenation variables.

Results Steady-state anaesthesia was obtained with minimal deviations in the regimen in some patients followed by reasonable recovery.

Conclusion It is concluded that infusion of ketamine and midazolam in the approximation regimen doses can be used to maintain anaesthesia for prolonged abdominal surgery.